Sentences with phrase «vaccine technology used»

The nanoparticle vaccine technology used in the study has been licensed by Parvus Therapeutics, Inc., a biotechnology company arising from the University Technology International LP, the technology transfer and commercialization center for the University of Calgary.

Not exact matches

Poland reckons doctors will be able to use the technology to predict whether a person is likely to respond to a vaccine, or if they are at risk of side effects.

VaxInnate is testing a universal flu vaccine that would work against all strains of the disease by using a Toll - like receptor (TLR) technology platform.

To create a new dengue virus vaccine, Stefan Metz, Shaomin Tian in the laboratories of Aravinda de Silva, Chris Luft and Joe DeSimone at the University of Carolina, Chapel Hill, USA designed nanoparticles of various shapes and sizes using Particle Replication in Non-wetting Template (PRINT) technology.

Currently, most influenza vaccines in the United States are produced using chicken eggs, while a few are made in cell culture or by using recombinant DNA technologies.

Examples include changing policies to encourage older adults to remain part of the workforce for longer (e.g., removing tax disincentives to work past retirement age), emphasising low - cost disease prevention and early detection rather than treatment (eg, reducing salt intake and increasing uptake of vaccines), making better use of technology (eg, mobile clinics for rural populations), and training health - care staff in the management of multiple chronic conditions.

5) Explore new vaccine technologies — Longer term, we need to evaluate new ways to vaccinate wild carnivores for distemper, in situations wherein use of an injectable vaccine is not feasible by hand or by dart.

Manufacturing vaccines can take about eight months because they are still produced using 1940s technology.

«Now I see how vaccine technology can be used against a host of public health issues.»

There are ongoing studies which focus on the discovery of molecular biomarkers of the VSV - ZEBOV vaccine in healthy individuals using omics - based technologies in combination with a systems biology approach,» says Ali Harandi.

Significantly, J&J's latest vaccine uses so - called mosaic technology to combine immune - stimulating proteins from different HIV strains, representing different types of virus from around the world, which should produce a «global» vaccine.

Using the same technology, it would be «really very simple» to make a pandemic vaccine, says Manon Cox, Protein Sciences» chief operating officer.

«It's the same technology WRAIR has used to successfully develop other flavivirus vaccines.»

The ability to design new protein nanostructures could have useful implications in targeted delivery of drugs, in vaccine development and in plasmonics — manipulating electromagnetic signals to guide light diffraction for information technologies, energy production or other uses.

Critics have pointed out that the same synthetic biology know - how and technologies could be used by terrorists or rogue states to engineer a bacterium that churns out a neurotoxin or, perhaps, a deadly flu virus with resistance to vaccines and antiviral medications.

The laboratory has also all of the technologies required to produce recombinant bacteria expressing vaccine antigens to be used as non-pathogenic vaccine vectors.

The technology also improves cell culture systems used to produce therapeutic proteins, vaccines, and gene therapy vectors.

Today UNIL - VFL provides access to adjuvants, adjuvant quality control technology, adjuvant formulation expertise, technology transfer, training, and bespoke adjuvant R&D services, allowing partners to gain optimal benefit from the use of adjuvants and vaccine formulation technology.

Finally, the HZI will help develop in vivo imaging technologies to characterize (i) vaccine biodistribution and persistence, and (ii) cellular and molecular changes at the injection site and in draining lymphoid tissues, helping to refine the use of animal models.

The Pilot Bioproduction Facility at WRAIR manufactured the ZPIV vaccine being used in Phase 1 clinical studies, and the Army recently signed a cooperative research and development agreement to transfer the ZPIV technology to Sanofi Pasteur to explore larger scale manufacturing and advanced development.

We use our mammalian expression technologies to create panels of recombinant pathogen proteins that are then used to identify new subunit vaccine targets for infectious diseases.

«This is a straightforward study of the use of two established vaccine technologies in an attempt to design and test new Zika vaccines.

Massachusetts Institute of Technology (MIT) researchers have discovered a new way to model malaria using stem cells in a petri dish, which will allow them to test potential antimalarial drugs and vaccines.

Scientific programs include: human genomic sequencing and analysis, synthetic genomics and exploration of new vaccines using this technology, and environmental and single cell genomics to explore the vast unseen world of microbes living in the human body, the ocean, soil and air.

Using enhanced DNA technology, the lab has designed DNA vaccines that drive immune responses in prophylactic or therapeutic settings against Human Immunodeficiency Virus (HIV), Dengue (DV), Chikungunya virus (CHIKV), Middle Eastern Respiratory Syndrome (MERS) virus, and Zika Virus (ZV).

Currently serving as a consultant for the international vaccine community, Michel De Wilde was among the first to use recombinant DNA technology in the industry and has contributed to the discovery and development of a number of vaccines.

One of the pandemic influenza projects Susan focuses on is development of an effective virus like particle (VLP) vaccine given intradermally, using microneedle technology.

This premature enthusiasm has more recently given way to caution as the technology has gradually been transferred to humans, with only limited short - term success.3 Finally, since HIV usually enters the body through mucosal surfaces — the vagina and rectum — augmenting an immune response at these portals of entry by using what scientists call mucosal AIDS vaccines might be an additional way to improve protection against infection.

There are many variations of H1N1, says Rafi Ahmed, director of the Emory Vaccine Center and a Georgia Research Alliance Eminent Scholar, but this technology could be used to identify a very specific strain, such as the one weâ $ ™ re dealing with in the current pandemic.

The Delta VP30 technology has been approved by the National Institutes of Health for use under Biosafety Level 2 conditions and has been utilized safely for a decade to study the basic biology of the virus, identify potential antiviral compound candidates, and make the whole - virus vaccine.

The space was also designed with the public in mind, featuring interactive tour stops throughout the lab space that use technology to underscore IDRI's work in developing vaccines, drugs and diagnostics, as well as large built - in windows to showcase IDRI's specialized facilities, including manufacturing.

VXGN has other potentially valuable assets, including a «a state - of - the - art biopharmaceutical manufacturing facility with a 1,000 - liter bioreactor that can be used to make cell culture or microbial biologic products» and rights to specified percentages of future net sales relating to its anthrax vaccine product candidate and related technology.

VXGN has other potentially valuable assets, including a «state - of - the - art biopharmaceutical manufacturing facility with a 1,000 - liter bioreactor that can be used to make cell culture or microbial biologic products» and rights to specified percentages of future net sales relating to its anthrax vaccine product candidate and related technology.

This is a new treatment that uses vaccine technology to eliminate one of the main mediators of itch sensation.

This may be because of improved vaccine technology and using only portions of the organism rather than the entire bacterium.

While the technology is new to flu vaccine production, it is used to make vaccines that have been approved by the FDA to prevent other infectious diseases.